Q2 2024 EPS Estimates for Moelis & Company (NYSE:MC) Decreased by Analyst

Moelis & Company (NYSE:MC) – Research analysts at Zacks Research dropped their Q2 2024 earnings per share estimates for shares of Moelis & Company in a research note issued on Friday, April 19th. Zacks Research analyst R. Department now forecasts that the asset manager will post earnings of $0.13 per share for the quarter, down from their previous estimate of $0.16. The consensus estimate for Moelis & Company’s current full-year earnings is $1.47 per share. Zacks Research also issued estimates for Moelis & Company’s Q3 2024 earnings at $0.33 EPS, FY2024 earnings at $1.24 EPS, Q2 2025 earnings at $0.66 EPS, Q1 2026 earnings at $0.70 EPS and FY2026 earnings at $4.01 EPS.

Moelis & Company (NYSE:MC) last released its quarterly earnings results on Wednesday, February 7th. The asset manager reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.05. The firm had revenue of $214.90 million for the quarter, compared to analyst estimates of $197.98 million. Moelis & Company had a negative return on equity of 3.82% and a negative net margin of 2.89%. Moelis & Company’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.33 EPS.

Other equities analysts have also issued reports about the company. Keefe, Bruyette & Woods reissued a “market perform” rating and set a $56.00 price target on shares of Moelis & Company in a research report on Monday, January 29th. JPMorgan Chase & Co. upped their target price on Moelis & Company from $46.00 to $57.00 and gave the company a “neutral” rating in a research report on Thursday, February 8th. JMP Securities reaffirmed a “market perform” rating on shares of Moelis & Company in a research report on Tuesday, April 9th. The Goldman Sachs Group raised Moelis & Company from a “sell” rating to a “neutral” rating and upped their target price for the company from $53.00 to $58.00 in a research report on Wednesday, March 13th. Finally, UBS Group cut their target price on Moelis & Company from $46.00 to $45.00 and set a “sell” rating on the stock in a research report on Tuesday, March 26th. Two investment analysts have rated the stock with a sell rating and five have assigned a hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $50.80.

Moelis & Company Stock Performance

Moelis & Company stock opened at $51.65 on Monday. The stock’s 50 day moving average price is $54.35 and its 200 day moving average price is $51.30. The firm has a market capitalization of $3.68 billion, a PE ratio of -143.47 and a beta of 1.35. Moelis & Company has a one year low of $33.87 and a one year high of $58.67.

Institutional Investors Weigh In On Moelis & Company

Large investors have recently added to or reduced their stakes in the stock. Mutual of America Capital Management LLC increased its holdings in shares of Moelis & Company by 26.8% during the fourth quarter. Mutual of America Capital Management LLC now owns 96,568 shares of the asset manager’s stock valued at $5,420,000 after purchasing an additional 20,413 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of Moelis & Company by 5.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 792,729 shares of the asset manager’s stock valued at $35,776,000 after purchasing an additional 42,424 shares during the period. Teza Capital Management LLC boosted its stake in Moelis & Company by 75.7% during the third quarter. Teza Capital Management LLC now owns 32,538 shares of the asset manager’s stock valued at $1,468,000 after buying an additional 14,016 shares in the last quarter. HighTower Advisors LLC boosted its stake in Moelis & Company by 3.2% during the third quarter. HighTower Advisors LLC now owns 1,111,200 shares of the asset manager’s stock valued at $50,144,000 after buying an additional 34,740 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in Moelis & Company by 0.4% during the third quarter. Vanguard Group Inc. now owns 7,787,483 shares of the asset manager’s stock valued at $351,449,000 after buying an additional 28,446 shares in the last quarter. 91.53% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Moelis & Company news, insider Christopher Callesano sold 1,040 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $53.59, for a total value of $55,733.60. The sale was disclosed in a document filed with the SEC, which is available through this link. In other Moelis & Company news, insider Christopher Callesano sold 1,040 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $53.59, for a total value of $55,733.60. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Kenneth Moelis sold 128,277 shares of the stock in a transaction on Wednesday, February 21st. The stock was sold at an average price of $52.60, for a total value of $6,747,370.20. Following the completion of the sale, the chief executive officer now directly owns 161,810 shares in the company, valued at $8,511,206. The disclosure for this sale can be found here. In the last ninety days, insiders sold 375,185 shares of company stock worth $20,130,225. 6.96% of the stock is currently owned by insiders.

Moelis & Company Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 28th. Stockholders of record on Tuesday, February 20th were issued a $0.60 dividend. The ex-dividend date of this dividend was Friday, February 16th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 4.65%. Moelis & Company’s dividend payout ratio (DPR) is -666.67%.

About Moelis & Company

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.